Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
354
mi
from 43215
Durham, NC
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
306
mi
from 43215
Winston-Salem, NC
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
2057
mi
from 43215
Eugene, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2057
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
2036
mi
from 43215
Springfield, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2036
mi
from 43215
Springfield, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
2031
mi
from 43215
Tualatin, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2031
mi
from 43215
Tualatin, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
1069
mi
from 43215
Austin, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
925
mi
from 43215
Bedford, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
925
mi
from 43215
Bedford, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
937
mi
from 43215
Fort Worth, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
862
mi
from 43215
Tyler, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
862
mi
from 43215
Tyler, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
407
mi
from 43215
Newport News, VA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
407
mi
from 43215
Newport News, VA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
437
mi
from 43215
Virginia Beach, VA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
437
mi
from 43215
Virginia Beach, VA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
2026
mi
from 43215
Vancouver, WA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2026
mi
from 43215
Vancouver, WA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
4146
mi
from 43215
Arlon,
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
4146
mi
from 43215
Arlon,
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1655
mi
from 43215
Chandler, AZ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1655
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1662
mi
from 43215
Phoenix, AZ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1979
mi
from 43215
Beverly Hills, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1972
mi
from 43215
Los Angeles, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1915
mi
from 43215
Redlands, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1915
mi
from 43215
Redlands, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
2039
mi
from 43215
Sacramento, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2039
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
2069
mi
from 43215
San Luis Obispo, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
2069
mi
from 43215
San Luis Obispo, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1960
mi
from 43215
Santa Ana, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1911
mi
from 43215
Victorville, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1911
mi
from 43215
Victorville, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1174
mi
from 43215
Golden, CO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1174
mi
from 43215
Golden, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
1164
mi
from 43215
Littleton, CO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
1164
mi
from 43215
Littleton, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
522
mi
from 43215
Bridgeport, CT
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
522
mi
from 43215
Bridgeport, CT
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
328
mi
from 43215
Washington,
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
823
mi
from 43215
Lakeland, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
823
mi
from 43215
Lakeland, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
842
mi
from 43215
St. Petersburg, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
842
mi
from 43215
St. Petersburg, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
831
mi
from 43215
Tampa, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
436
mi
from 43215
Atlanta, GA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
274
mi
from 43215
Chicago, IL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
166
mi
from 43215
Indianapolis, IN
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
460
mi
from 43215
Iowa City, IA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
809
mi
from 43215
Ellsworth, ME
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
809
mi
from 43215
Ellsworth, ME
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
344
mi
from 43215
Baltimore, MD
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
641
mi
from 43215
Cambridge, MA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
641
mi
from 43215
Cambridge, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
634
mi
from 43215
Waltham, MA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
634
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
163
mi
from 43215
Detroit, MI
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
176
mi
from 43215
Royal Oak, MI
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
559
mi
from 43215
Rochester, MN
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
660
mi
from 43215
Jackson, MS
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
660
mi
from 43215
Jackson, MS
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
395
mi
from 43215
St. Louis, MO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
682
mi
from 43215
Omaha, NE
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
468
mi
from 43215
Bloomfield, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
468
mi
from 43215
Bloomfield, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
478
mi
from 43215
Palisades Park, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
478
mi
from 43215
Palisades Park, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
477
mi
from 43215
Teaneck, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
477
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
481
mi
from 43215
New York, NY
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
343
mi
from 43215
Belmont, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
343
mi
from 43215
Belmont, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
350
mi
from 43215
Charlotte, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
306
mi
from 43215
Winston-Salem, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials